■5-氟尿嘧啶(5-FU)是一种广泛使用的化学治疗剂,可引起心脏毒性表现,其中,如胸痛。卡培他滨是5-FU的口服前药,据报道,恶性细胞优先激活,也可能引起心脏毒性反应。用血管扩张剂标准治疗5-FU和卡培他滨引起的胸痛最有效,但是有几例患者对这些药物没有反应。
■我们于2020年5月31日进行了PubMed搜索。我们使用了使用布尔搜索运算符的三个关键字搜索策略。更具体地说,我们纳入了氟尿嘧啶或5-FU或卡培他滨和胸痛或心绞痛以及机制或治疗或管理.我们纳入了临床和非临床数据的主要报告,以及系统评价。叙事评论,专家意见,给编辑的信件和其他形式的非主要文献被排除在外。
■我们的搜索总共产生了1595份报告。其中,1460是叙述性评论或与主题无关,被排除在外。共有135份报告用于我们的审查。我们使用了81份报告进行数据提取,其中包括13项临床试验,4份回顾性报告,61例病例报告,和3个系统评价。
■我们报告了发病率和诱发因素,可用诊断程序的价值,以及标准的医疗和侵入性治疗。我们还推测精氨酸在预防和治疗5-FU引起的胸痛方面的潜在益处。最后,发现了证据的差距,并就未来的研究提出了建议。
UNASSIGNED: 5-Fluorouracil (5-FU) is a widely used chemotherapeutic agent that can cause cardiotoxicity manifesting, among others, as chest pain. Capecitabine is an oral prodrug of 5-FU, with reported preferential activation in malignant cells that may also cause cardiotoxic reactions. Standard treatment of 5-FU and capecitabine induced chest pain with vasodilators is mostly effective, but there are several cases of patients unresponsive to these agents.
UNASSIGNED: We performed a PubMed search on 31st May 2020. We used a three keyword search strategy using Boolean search operators. More specifically, we included fluorouracil or 5-FU or capecitabine and chest pain or angina and mechanism or treatment or management. We included primary reports of clinical and non-clinical data, as well as systematic reviews. Narrative reviews, expert opinions, letters to the editor and other forms of non-primary literature were excluded.
UNASSIGNED: Our search yielded a total of 1595 reports. Of these, 1460 were narrative reviews or irrelevant to the topic and were excluded. A total of 135 reports were used for our
review. We used 81 reports for data extraction, which included 13 clinical trials, 4 retrospective reports, 61 case reports, and 3 systematic reviews.
UNASSIGNED: We report the incidence and predisposing factors, the value of available diagnostic procedures, and standard medical and invasive treatments. We also speculate on the potential benefit of arginine as a promising option both in prevention as well as treatment of 5-FU-induced chest pain. Finally, gaps of evidence are identified and proposals are made in terms of future research.